Evaluation of an Intervention for Optimizing Pregnant Women's Adherence to Maternal Multiple Micronutrients Supplements
調査の概要
状態
状態
条件
条件
介入・治療
介入・治療
詳細な説明
Research has shown that antenatal multiple micronutrient supplementation (MMS), a daily dose of 15 vitamins and minerals, is just as effective as iron and folic acid supplementation (IFAS) in preventing maternal anaemia, more effective at improving birth outcomes and is safe for mothers and babies.
In 2020, the World Health Organization (WHO) released an updated guidance recommending that implementation research (IR) be conducted in settings where the transition from IFAS to MMS is being considered in low- and middle- income countries. IR can help countries understand how to best design and implement effective intervention in real-life settings and can be used to identify and investigate challenges that prevent effective implementation.
In line with the WHO's recommendation, in 2021, the Nigeria Federal Ministry of Health approved the use of MMS during pregnancy and called for implementation research (IR) in the updated National Guidelines for the Prevention and Control of Micronutrient Deficiencies in Nigeria.
Based on national stakeholders' identification of a critical need for context-specific implementation evidence, efforts focused on understanding how MMS can be effectively delivered, accepted, and adhered to within the Nigerian health system, particularly in light of the implementation bottlenecks and adherence gaps previously documented in IFAS programs.
This IR project aims to evaluate implementation approaches on optimizing pregnant women's adherence to MMS. One of the components of this IR project is an outcome evaluation - the focus of this protocol - that seeks to answer the following research questions:
Primary research questions:
• Does implementation of these implementation approaches increase pregnant women's adherence to MMS?
Secondary research questions:
- Are the implementation approaches acceptable to key stakeholders?
- Does implementation of the implementation approaches increase the quality of care/nutrition counseling in ANC?
The implementation approaches focused on:
- Strengthening the capacity building of healthcare workers and community members
- Improving nutrition counselling integrated into ANC delivery with an emphasis on MMS adherence
- Engaging pregnant woman's family members (husbands) and influential community members to support maternal health and nutrition
An outcome evaluation was completed using a cluster randomized controlled trial (cRCT) with cross-sectional baseline (prior to the introduction of the implementation approaches) and endline (approximately 2 years after the introduction of the introduction of the implementation approaches) surveys among pregnant women, their husbands and healthcare workers (HCWs) across the three Local Government Areas (LGAs) in Bauchi State. MMS was integrated into routine ANC across the state prior to the baseline assessment.
Nutrition International worked closely with the Bauchi state government to select 3 LGAs (Dass, Ganjuwa and Giade) representing the north, central and southern parts of the state. This decision was made taking into consideration state representation key criteria such as religious demographic, ANC attendance, security, IFA utilization and socio-economic distribution. These LGAs comprise a total of 42 wards all of which were designated as study clusters for the intervention and control arms. Out of these 42 wards, a simple random selection was used to randomly allocate 22 wards to the intervention arm and 20 to the control arm across the three target LGAs:
- Control arm: Eligible pregnant women in these study sites receive MMS as part of their standard ANC.
- Intervention arm: Eligible pregnant women in these study sites receive MMS alongside the implementation approaches as part of their standard ANC.
A third observational arm was selected from a separate LGA where MMS had not been introduced and IFAS continued to be the standard of care to help contextualise differences between the intervention and control arms.
Quantitative and qualitative data were collected from participants through interviewer-administered questionnaires and focus group discussions. The study measured adherence through several methods including self-reported daily consumption, average consumption rate over a three-month period, and a physical pill count by the data collector. Difference-in-difference analysis will be used to assess whether the implementation approaches increased MMS adherence at endline. Descriptive statistics will be used to determine whether the adherence solutions are acceptable to healthcare workers, pregnant women, and their husbands.
研究の種類
研究の種類
入学 (実際)
入学
段階
段階
- 適用できない
連絡先と場所
研究場所
-
-
Bauchi
-
Dass、Bauchi、ナイジェリア
- Public health facilities in Dass
-
Ganjuwa、Bauchi、ナイジェリア
- Public health facilities in Ganjuwa
-
Giade、Bauchi、ナイジェリア
- Public health facilities in Giade
-
-
参加基準
適格基準
適格基準
就学可能な年齢
- 子
- 大人
- 高齢者
健康ボランティアの受け入れ
説明
Inclusion Criteria:
Pregnant/post-partum women
- Women of reproductive age (15-49 years of age)
- Pregnant or up to 3 months post-partum women
- Having reportedly received at least one MMS bottle at least 30 days before start of data collection from a participating public health facility-
- Provide consent for participation
Health Care Workers (HCWs)
- HCWs providing ANC services including MMS and IFAs to pregnant women at the selected health facilities
Husbands
- Husbands of the enrolled pregnant women At endline, the same criteria apply.
Exclusion Criteria:
- Anemic pregnant women
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 主な目的:ヘルスサービス研究
- 割り当て:ランダム化
- 介入モデル:並列代入
- マスキング:なし(オープンラベル)
アーム数
武器と介入
参加者グループ / アーム参加者グループ / アーム |
介入・治療介入・治療 |
|---|---|
|
介入なし:コントロールアーム
|
|
|
実験的:Intervention Arm
Eligible pregnant women received implementation approaches
|
Implementation approaches are human-centered designed strategies aimed at optimizing pregnant women's daily adherence to MMS.
|
この研究は何を測定していますか?
主要な結果の測定
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Adherence to MMS
時間枠:At baseline and approximately 2 years after (endline)
|
Defined as "when pregnant women consume the right dose of multiple micronutrient supplementation (MMS) at the right time throughout pregnancy". Measured through self-reported daily consumption, self-reported average consumption rate over a three-month period, and pill count. |
At baseline and approximately 2 years after (endline)
|
二次結果の測定
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Acceptability
時間枠:At baseline and approximately 2 years after (endline)
|
Defined as stakeholders' attitude towards MMS and its introduction as part of ANC. Assessed through surveys (Likert scale). The Likert scale is a 5 point scale quantifying attitudes from "strongly agree" to "strongly disagree". |
At baseline and approximately 2 years after (endline)
|
協力者と研究者
捜査官
捜査官
- 主任研究者:Babajide Adebisi、Nutrition International
- 主任研究者:Jennifer Busch Hallen、Nutrition International
研究記録日
主要日程の研究
研究開始 (実際)
研究開始
一次修了 (実際)
一次修了
研究の完了 (実際)
研究の完了
試験登録日
最初に提出
最初に提出
QC基準を満たした最初の提出物
QC基準を満たした最初の提出物
最初の投稿 (実際)
最初の投稿
学習記録の更新
投稿された最後の更新 (実際)
投稿された最後の更新
QC基準を満たした最後の更新が送信されました
QC基準を満たした最後の更新が送信されました
最終確認日
最終確認日
詳しくは
本研究に関する用語
その他の研究ID番号
その他の研究ID番号
- NI-07-2023-MMSN
個々の参加者データ (IPD) の計画
個々の参加者データ (IPD) を共有する予定はありますか?
IPD プランの説明
IPD 共有時間枠
IPD 共有アクセス基準
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。